Skip to main content
. 2014 Apr 23;14:79. doi: 10.1186/1471-230X-14-79

Figure 3.

Figure 3

Design of the explorative phase IIa study. Steroid resistant and steroid dependent UC patients were included in a placebo controlled double-blind study to re-affirm the target group for the treatment with DIMS0150 and for evaluation of biomarkers. (Black arrow) efficacy measure time point, (dashed arrow) follow-up time point.